Halozyme Therapeutics, Inc. ( NASDAQ:HALO – Get Rating ) CEO Helen Torley sold 10,000 shares of the business's stock in a transaction on Thursday, March 9th. The stock was sold at an average price of $42.73, for a total value of $427,300.00. Following the transaction, the chief executive officer now owns 623,666 shares in the company, valued at $26,649,248.18. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink . Helen Torley also recently made the following trade(s): On Tuesday, March 7th, Helen Torley sold 10,000 shares of Halozyme Therapeutics stock.

https://www.dailypolitical.com/2023/03/10/insider-selling-halozyme-therapeutics-inc-nasdaqhalo-ceo-sells-10000-shares-of-stock.html

#dailypolitical